| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/17/2004 | CN1482916A Vaccine composite containing invert growth factor a |
| 03/17/2004 | CN1482139A Mucroslysin protein and gene thereof |
| 03/17/2004 | CN1481897A Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and use |
| 03/17/2004 | CN1481895A Use of mannan peptide in preparation of immunologic enhancement medication which is topically and orally applicated |
| 03/17/2004 | CN1481894A Drug composition, its preparation method and use |
| 03/17/2004 | CN1481892A Reptile phrynosoma tablet for curing pulmonary disease |
| 03/17/2004 | CN1481886A Nanometer Chinese traditional medicine for prevention of atypical pneumonia |
| 03/17/2004 | CN1481874A Capsule for fortifying kidney and nourishing qi and its preparation mehtod |
| 03/17/2004 | CN1481866A Healthcare food with function of wetting one's whistle |
| 03/17/2004 | CN1481864A Soup for detoxification |
| 03/17/2004 | CN1481858A Preparation method of glabrous sarcandra herb capsule |
| 03/17/2004 | CN1481812A Spray formulation of providone iodine |
| 03/17/2004 | CN1481792A Andrographolide soft capsule formulation and preparation method |
| 03/17/2004 | CN1481791A Andrographolide microcapsule and its preparation method |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1142144C 4-phenyl pyridine derivatives |
| 03/17/2004 | CN1141947C Syrup for treating cough and asthma and its production Process. |
| 03/16/2004 | US6706892 Adminstering maleimide derivative to covalently bond protein; wound healing, antibiotic, antiinflammatory, anticarcinogenic, hypotensive, and analgesic agents |
| 03/16/2004 | US6706753 Integrin receptor inhibitors |
| 03/16/2004 | US6706750 Useful in treating obesity and other disorders |
| 03/16/2004 | US6706743 β3 adrenergic receptor agonists and uses thereof |
| 03/16/2004 | US6706738 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706727 ethyl-4-chloro- or 4-hydroxy- Ascomycin derivatives; pimecrolimus homologues; cultivating Streptomyces hygroscopius to produce the 4-hydroxy derivative; replacement of the hydroxy with chloro under epimerization; antiinflammatory; immunosupression |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | US6706703 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (ige) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/16/2004 | US6706695 Antilipemic formulation |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity |
| 03/16/2004 | CA2265651C Immediate wettability water soluble film or water soluble layer for oral application |
| 03/11/2004 | WO2004020584A2 Antagonists of chemokine receptors |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020433A1 Novel crystals |
| 03/11/2004 | WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/11/2004 | WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 03/11/2004 | WO2004020289A1 Process for producing metered dose inhaler formulations |
| 03/11/2004 | WO2004019986A1 Methods of treating acute respiratory distress syndrome |
| 03/11/2004 | WO2004019985A1 Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
| 03/11/2004 | WO2004019984A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd |
| 03/11/2004 | WO2004019979A2 Vaccine comprising il-13 and an adjuvant |
| 03/11/2004 | WO2004019975A2 Il-14 vaccine for the treatment of asthma and atopic disorders |
| 03/11/2004 | WO2004019974A2 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 03/11/2004 | WO2004019955A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019945A1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 03/11/2004 | WO2004019944A1 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 03/11/2004 | WO2004019936A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2004019865A2 Amelioration of effects of cigarette smoke |
| 03/11/2004 | WO2003099759A8 Preparation and application of transhintotalphenolic acid |
| 03/11/2004 | WO2003094840A3 Induction of antigen specific immunologic tolerance |
| 03/11/2004 | WO2003092599A3 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 03/11/2004 | WO2003090715A3 Particulate materials |
| 03/11/2004 | WO2003082861A3 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases |
| 03/11/2004 | WO2003057133A3 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 03/11/2004 | WO2003053945A3 Urea derivatives and their use as vanilloid receptor antagonists |
| 03/11/2004 | WO2003043614A3 Reversible proton pump inhibitors for the treatment of airway disorders |
| 03/11/2004 | WO2003014316A3 Immunomodulatory compositions, formulations, and methods for use thereof |
| 03/11/2004 | WO2003011294A3 Mucin synthesis inhibitors |
| 03/11/2004 | WO2003000695A8 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002072802A3 Live attenuated strains of prrs virus |
| 03/11/2004 | US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents |
| 03/11/2004 | US20040049031 Method for the synthesis of quinoline derivatives |
| 03/11/2004 | US20040048931 Modafinil pharmaceutical compositions |
| 03/11/2004 | US20040048907 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048902 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 03/11/2004 | US20040048901 Increased water solubility and bioabsorption; treatment of CNS disorders such as depression and emesis |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048881 Quinazoline derivatives with anti-tumour activity |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics. |
| 03/11/2004 | US20040048865 Aliphatic amino group-substituted fused ring pyrimidines or pyridines such as 2,4 dichloro-pyrido-(2,3-d)- or -(3,2d)-pyrimidines, 5,7-dichloro-(1,6) napthyridines, or 2,4-dichloro-(1,8)napthyridines |
| 03/11/2004 | US20040048862 Chemical compounds |
| 03/11/2004 | US20040048859 Substituted glutarimides and their use as inhibitors of IL-12 production |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048850 Activators of soluble guanylate cyclase. |
| 03/11/2004 | US20040048843 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 03/11/2004 | US20040048820 Prevention or therapy of cardiovascular complications |
| 03/11/2004 | US20040048795 Stimulating a vagus nerve pathway in the brain; inhibiting apoptosis of a cardiac myocyte |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040047860 Antibodies to human mcp-1 |
| 03/11/2004 | US20040047846 Ubiquitin promoter in vectors for gene therapy in respiratory tract |
| 03/11/2004 | US20040047810 Microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the |